Drug safety test halted: how liver health changes medication
NCT ID NCT05126329
Summary
This study aimed to understand how liver function affects the processing of the breast cancer drug amcenestrant. It involved 13 female participants, some with mild to moderate liver impairment and others with normal liver function, who received a single dose. The main goal was to measure drug levels in the blood to see if liver problems change how the body handles the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC FUNCTION ABNORMAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :2760001
Kiel, 24105, Germany
-
Investigational Site Number :4100001
Seoul, Seoul-teukbyeolsi, 03080, South Korea
-
Investigational site number :4100002
Cheongju-si, 28644, South Korea
Conditions
Explore the condition pages connected to this study.